Anais Courtier

Grenoble, 38000, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Serum biomarkers fail to predict response to adalimumab in axial spondyloarthritis: Results from discovery and validation cohorts.

Serum biomarkers fail to predict response to adalimumab in axial spondyloarthritis: Results from discovery and validation cohorts.

Journal: Joint bone spine
Published: November 20, 2025

Serum calprotectin is increased in early axial spondyloarthritis with sacroiliitis and objective signs of inflammation: Results from the DESIR cohort.

Serum calprotectin is increased in early axial spondyloarthritis with sacroiliitis and objective signs of inflammation: Results from the DESIR cohort.

Journal: Joint bone spine
Published: May 18, 2020

Fetuin-A and thyroxin binding globulin predict rituximab response in rheumatoid arthritis patients with insufficient response to anti-TNFα.

Fetuin-A and thyroxin binding globulin predict rituximab response in rheumatoid arthritis patients with insufficient response to anti-TNFα.

Journal: Clinical rheumatology
Published: November 25, 2019

Apolipoprotein C1 in synovial fluid discriminates septic arthritis from rheumatoid arthritis but not from pseudogout.

Apolipoprotein C1 in synovial fluid discriminates septic arthritis from rheumatoid arthritis but not from pseudogout.

Journal: Clinical rheumatology
Published: August 09, 2019

Calprotectin alone is not sufficient to predict response to methotrexate in early ACR/EULAR 2010 rheumatoid arthritis: Analysis of the ESPOIR cohort.

Calprotectin alone is not sufficient to predict response to methotrexate in early ACR/EULAR 2010 rheumatoid arthritis: Analysis of the ESPOIR cohort.

Journal: Joint bone spine
Published: May 21, 2019

Calprotectin discriminates septic arthritis from pseudogout and rheumatoid arthritis.

Calprotectin discriminates septic arthritis from pseudogout and rheumatoid arthritis.

Journal: Rheumatology (Oxford, England)
Published: November 08, 2018

Systemic calprotectin and chronic inflammatory rheumatic diseases.

Systemic calprotectin and chronic inflammatory rheumatic diseases.

Journal: Joint bone spine
Published: September 22, 2018

Prealbumin, platelet factor 4 and S100A12 combination at baseline predicts good response to TNF alpha inhibitors in rheumatoid arthritis.

Prealbumin, platelet factor 4 and S100A12 combination at baseline predicts good response to TNF alpha inhibitors in rheumatoid arthritis.

Journal: Joint bone spine
Published: March 27, 2018

Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma.

Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma.

Journal: Cancer immunology research
Published: March 05, 2018

Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma.

Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma.

Journal: Journal for immunotherapy of cancer
Published: March 19, 2015

Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes.

Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes.

Journal: European heart journal
Published: July 16, 2013

Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.

Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.

Journal: Oncoimmunology
Published: July 04, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026